Studies have found [38] that specific Enterococcus, mainly Enterococcus faecium, E.durans, E.irae and E.Meundtii, have the ability to enhance the potency of anti-PD-L1 immunotherapy for cancer. The gene discussed is CD274; the disease is cancer.